Citation Impact
Citing Papers
Phase I Study of RGB-286638, A Novel, Multitargeted Cyclin-Dependent Kinase Inhibitor in Patients with Solid Tumors
2014
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Current knowledge on exosome biogenesis and release
2017 Standout
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis
2006
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
2013 Standout
Consensus development in acute renal failure: the Acute Dialysis Quality Initiative
2005
Acute kidney injury
2012 Standout
Acute Renal Failure in Patients with Sepsis in a Surgical ICU
2003
Mechanism and medical implications of mammalian autophagy
2018 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Has mortality from acute renal failure decreased? A systematic review of the literature
2005
Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure
2007
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Global epidemiology and outcomes of acute kidney injury
2018 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
A chemical probe toolbox for dissecting the cancer epigenome
2017
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Acute kidney injury
2021 Standout
Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey
2003
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Changes in blood pressure before the development of nosocomial acute kidney injury
2008
Incidence of Acute Renal Failure in the Intensive Care Unit
2001
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
2014
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
The PI3K Pathway in Human Disease
2017 Standout
ROS and the DNA damage response in cancer
2018 Standout
Acute Renal Failure in the Critically Ill: Impact on Morbidity and Mortality
2004
Research into cancer metabolomics: Towards a clinical metamorphosis
2015
Systemic Microvascular Leak in an In Vivo Rat Model of Ventilator-induced Lung Injury
2003
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Incidence of chronic lymphocytic leukemia and high‐count monoclonal B‐cell lymphocytosis using the 2008 guidelines
2014
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma
2014
2016
Fundamentals of cancer metabolism
2016 Standout
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding
2013
Discovery of piperlongumine as a potential novel lead for the development of senolytic agents
2016
Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells
2016
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome.
2017 Standout
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space
2017
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
2013
Works of Francesca Cottini being referenced
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma
2015
Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma
2014
Risk factors for acute renal failure in trauma patients
1998
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
2013
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
2015
Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals
2010
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs
2013
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma
2015
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL
2011
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
2012